Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Dual‐Adjuvanted Parenteral‐Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS‐CoV‐2 in Mice

Advanced Science(2024)10.1002/advs.202402792Source: DataRank Database

A Dual‐Adjuvanted Parenteral‐Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS‐CoV‐2 in Mice is a research paper published in Advanced Science (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.14)OA: goldTopics (62)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Zhengying Wang,Angela Jimenez ORCID,Eshant Bhatia ORCID,Ritika Jain ORCID,Alexander Beach

Live enrichment

PubMed:39352717 PMC:PMC11615772 OpenAlex:https://openalex.org/W4403027387

National Institutes of Health- National Institute of Allergy and Infectious Disease

Grant: U01-AI124270

NIAID NIH HHS

Grant: U01 AI124270

National Institutes of Health

Grant: 3U01AI124270-05S1

Effect of presentation methods on the molecular mechanism of combinatorial adjuvants

Georgia Tech Foundation

Robert A. Milton Chaired Professorship to Krishnendu Roy

FWCI

2.14

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202402792

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202402792

journalhttps://doi.org/10.1002/advs.202402792

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39352717

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11615772

Fields of Study

SARS-CoV-2 and COVID-19 ResearchBacterial Infections and VaccinesImmunotherapy and Immune Responses0301 basic medicine03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAdjuvants, VaccineNanovaccinesAdjuvants, ImmunologicAdministration, IntranasalAnimalsAntibodies, ViralFemaleMice, Inbred BALB CImmunity, MucosalVaccines, SubunitMiceNanoparticlesAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

ImmunityCpG OligodeoxynucleotideNasal administrationImmunologyCellular immunityAntibodyProtein subunitHumoral immunityVirologyMucosal immunityImmune systemMedicineBiologyGeneBiochemistryPolymer NanoparticlesAntiviral ImmunityCombination AdjuvantsParenteral And Intranasal VaccinationSars‐cov‐2 Subunit NanovaccineCOVID-19 VaccinesScienceNanovaccinesAntibodies, ViralMiceAdjuvants, ImmunologicAnimalsAdjuvants, VaccineImmunity, MucosalAdministration, IntranasalMice, Inbred BALB CSARS-CoV-2QCOVID-19Antibodies, NeutralizingVaccines, SubunitSpike Glycoprotein, CoronavirusNanoparticlesFemaleResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being